Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 USD | +5.24% |
|
+0.91% | +3.27% |
Business Summary
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
David Margrave
DFI | Director of Finance/CFO | 64 | 18-05-31 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Kishor Bhatia
CTO | Chief Tech/Sci/R&D Officer | 69 | 19-11-30 |
Ernest Kitt
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
Director/Board Member | 73 | 22-06-07 | |
Donald Keyser
CHM | Chairman | 71 | 17-12-31 |
Vijay Chandru
BRD | Director/Board Member | 70 | 19-09-30 |
Director/Board Member | 73 | 18-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,758,805 | 9,171,558 ( 85.25 %) | 0 | 85.25 % |
Company contact information
![address Lantern Pharma Inc.(LTRN)](https://cdn.zonebourse.com/static/address/108225202.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.27% | 47.55M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- LTRN Stock
- Company Lantern Pharma Inc.